Max Healthcare Institute Ltd

Max Healthcare Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Max Healthcare Institute Ltd

₹ 1,165 -1.31%
20 Dec - close price
maxhealthcare.in BSE: 543220 NSE: MAXHEALTH
About

Max Healthcare Institute Limited is primarily engaged in the providing healthcare services through primary care clinics, multi-speciality hospitals / medical centres and super-speciality hospitals providing operation and management, medical services, clinical, radiology, pathology services and related healthcare services. [1]

Key Points

Leadership[1]
Max Healthcare is India’s second largest hospital chain in terms of revenue, EBITDA and market capitalisation.

Website BSE NSE
  • Market Cap ₹ 1,13,273 Cr.
  • Current Price ₹ 1,165
  • High / Low ₹ 1,216 / 651
  • Stock P/E 144
  • Book Value ₹ 81.7
  • Dividend Yield 0.13 %
  • ROCE 11.7 %
  • ROE 9.34 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is almost debt free.
  • Company has delivered good profit growth of 100% CAGR over last 5 years

Cons

  • Stock is trading at 14.3 times its book value
  • Company has a low return on equity of 8.49% over last 3 years.
  • Earnings include an other income of Rs.357 Cr.
  • Promoter holding has decreased over last 3 years: -37.2%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Healthcare Industry: Healthcare

Part of Nifty LargeMidcap 250 BSE 400 MidSmallCap Index BSE MidCap Nifty Midcap 100 Nifty Midcap 50

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
462 398 393 440 474 482 507 544 597 591 610 621 686
353 294 298 317 322 328 354 384 394 391 411 423 461
Operating Profit 109 104 96 123 152 154 154 160 203 200 199 198 225
OPM % 24% 26% 24% 28% 32% 32% 30% 29% 34% 34% 33% 32% 33%
30 42 27 29 32 44 41 43 48 43 138 43 134
Interest 15 11 13 13 13 13 14 14 13 10 15 8 8
Depreciation 28 25 28 28 28 28 30 28 28 30 32 30 32
Profit before tax 96 110 82 111 144 157 151 161 210 203 291 203 318
Tax % 23% 5% 19% 22% -149% 22% 16% 22% 23% 22% 17% 24% 27%
75 104 67 87 359 122 126 126 161 158 242 154 231
EPS in Rs 0.77 1.07 0.69 0.90 3.70 1.26 1.30 1.30 1.66 1.63 2.49 1.59 2.38
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
591 790 912 984 1,059 1,008 59 1,031 1,775 1,905 2,341 2,508
615 768 890 941 1,048 976 65 870 1,332 1,321 1,579 1,686
Operating Profit -24 22 22 43 11 31 -6 161 443 584 762 822
OPM % -4% 3% 2% 4% 1% 3% -10% 16% 25% 31% 33% 33%
39 33 35 30 51 47 66 -104 128 144 271 357
Interest 42 43 30 35 41 44 60 112 59 52 52 40
Depreciation 31 49 50 51 49 53 3 91 112 113 117 124
Profit before tax -58 -38 -24 -13 -28 -18 -3 -146 400 563 865 1,015
Tax % -0% -0% -0% -0% -0% 26% -5% 12% 17% -23% 21%
-58 -38 -24 -13 -28 -23 -3 -164 332 694 687 785
EPS in Rs -1.46 -0.78 -0.44 -0.24 -0.51 -0.43 -0.06 -1.70 3.42 7.15 7.07 8.09
Dividend Payout % -0% -0% -0% -0% -0% -0% -0% -0% -0% 14% 21%
Compounded Sales Growth
10 Years: %
5 Years: 18%
3 Years: 31%
TTM: 18%
Compounded Profit Growth
10 Years: %
5 Years: 100%
3 Years: 121%
TTM: 47%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: 43%
1 Year: 80%
Return on Equity
10 Years: %
5 Years: 7%
3 Years: 8%
Last Year: 9%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 395 489 533 537 537 537 537 966 970 971 972 972
Reserves 167 523 762 770 773 749 2,338 4,973 5,342 6,071 6,709 6,973
505 296 273 314 386 390 658 480 556 534 443 503
223 141 171 210 278 274 20 724 945 845 945 1,181
Total Liabilities 1,290 1,449 1,740 1,832 1,973 1,951 3,553 7,143 7,812 8,420 9,069 9,629
468 430 424 429 502 479 90 2,989 4,493 4,485 4,717 4,908
CWIP 10 15 6 30 7 10 -0 8 60 103 235 154
Investments 238 451 840 866 799 770 2,471 2,379 1,447 1,475 1,915 1,941
574 554 469 508 665 693 992 1,766 1,811 2,358 2,202 2,626
Total Assets 1,290 1,449 1,740 1,832 1,973 1,951 3,553 7,143 7,812 8,420 9,069 9,629

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
39 64 33 52 -19 128 224 447 696 613
-200 -330 -66 -89 55 -193 -105 -670 302 -806
176 251 34 36 -36 329 412 -161 -54 -246
Net Cash Flow 15 -16 0 -0 -0 265 532 -384 944 -438

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 97 67 48 55 68 103 517 109 56 27 32
Inventory Days 18 20 18 19 22 25 33 20 31 24
Days Payable 158 171 183 206 250 335 297 159 230 225
Cash Conversion Cycle -42 -85 -117 -132 -161 -206 517 -155 -83 -172 -169
Working Capital Days 27 3 2 4 -4 32 3,558 35 12 -39 -26
ROCE % 0% 1% 1% 2% 2% 4% 7% 9% 12%

Shareholding Pattern

Numbers in percentages

Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
60.68% 50.64% 50.64% 23.80% 23.78% 23.77% 23.76% 23.76% 23.75% 23.75% 23.74% 23.74%
16.67% 14.59% 23.34% 49.27% 50.15% 51.96% 59.89% 60.39% 60.69% 57.33% 56.99% 57.29%
15.67% 17.57% 19.42% 21.16% 20.47% 19.36% 11.90% 11.40% 11.55% 14.96% 15.36% 15.14%
6.97% 17.20% 6.61% 5.76% 5.61% 4.92% 4.45% 4.45% 3.99% 3.97% 3.91% 3.84%
No. of Shareholders 1,11,8771,20,0791,05,0001,01,6591,11,7011,04,6561,11,3741,18,6351,11,3381,27,0091,36,2541,37,856

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls